Antimicrobial Susceptibility Testing  Market growing with a CAGR of 5.9%, size, Segments, Growth Analysis

Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2022 to 2029 and is expected to reach USD 5,688.50 million by 2029 from USD 3,616.78 million in 2021. The high prevalence of infectious diseases and increasing awareness towards early diagnosis is the major driver which is propelling the market in the forecast period.

View Detailed Report: https://www.databridgemarketresearch.com/reports/global-antimicrobial-susceptibility-testing-market

Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen.

Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance. Delay in diagnosing the harmful microbes makes it difficult to control the spread of infectious diseases. This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.

Testing is used to determine the potential effectiveness of antibiotics on microorganisms and determine if the microorganisms have developed resistance to certain antibiotics. The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.

Key Players Analysis:

The major companies which are dealing in the antimicrobial susceptibility testing market are BD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc.,  Rosco Diagnostica A/S, ERBA Group, Liofilchem S.r.l., Alifax S.r.l., MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, Merck KGaA, Danaher, Accelerate Diagnostics, Inc., NuMedii, Inc., and BacterioScan, Inc. among others.among other domestic and Asia-Pacific players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separatelyMany product launch and agreement are also initiated by the companies' worldwide which are also accelerating the antimicrobial susceptibility testing market.

Global Antimicrobial Susceptibility Testing Market Scope and Market Size

Global antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end user and distribution channel.

On the basis of product type, antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software. In 2022, instruments segment is expected to dominate the market as most companies are launching instruments for antimicrobial susceptibility testing.

On the basis of methods, antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others. In 2022, disk diffusion method is expected to dominate as this method provides the accurate, reliable, and efficient results.

On the basis of type, antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others. In 2022, antibacterial testing segment is expected to dominate the market due to wide number of tests for antibacterial testing available in the market.

On the basis of application, antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology and others. In 2022, clinical diagnostics segment is expected to dominate the market because these tests are most frequently done for clinical diagnosis.

On the basis of end user, antimicrobial susceptibility testing market is segmented into hospitals, pharmaceuticals and biotechnology companies, diagnostic laboratories, contract research organizations, research centres & academic institutes and others. In 2022, hospitals segment is expected to dominate market because these antimicrobial tests are performed in hospitals to a great extent with latest technologies available.

On the basis of distribution channel, antimicrobial susceptibility testing market is segmented into direct sales, retail sales and third party distributor. In 2022, direct sales segment is expected to dominate the market because consumers are aware of this distribution channel and they prefer direct sales for seeking the benefits of discounts, bulk buying and easy availability of products.

Explore More Reports:

https://dbmrresearchreports.blogspot.com/2024/05/stealth-warfare-market-to-grow-at-cagr.html

https://dbmrresearchreports.blogspot.com/2024/05/air-brake-system-market-to-reach-usd.html

https://dbmrresearchreports.blogspot.com/2024/05/fatty-methyl-ester-sulfonates-market-to.html

https://dbmrresearchreports.blogspot.com/2024/05/solid-state-chip-battery-market-to.html

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:    
Data Bridge Market Research

Tel: +1 614-591-3140 | +44 845 154 9652 | +653 1251 975

Email: 
Corporatesales@databridgemarketresearch.com

This release was published on openPR.